Riomet | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Riomet
Annual Reports

PharmaCompass Sponsored Ads

Contact Supplier

Metformin

Contact Supplier

pharmacompass-1-m-2025-08-25

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Riomet

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

179 API Suppliers, 57 USDMF, 42 CEP/COS, 13 JDMF, 31 EU WC, 99 KDMF, 39 NDC API, 46 Listed Suppliers, $ API Reference Price

179 API Suppliers
57 USDMF
42 CEP/COS
13 JDMF
31 EU WC
99 KDMF
39 NDC API
46 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

651 Drugs in Development

651 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1937 FDF Dossiers, 431 FDA Orange Book, 534 Europe, 134 Canada, 136 Australia, 140 South Africa, 562 Listed Dossiers

1937 FDF Dossiers
431 FDA Orange Book
534 Europe
134 Canada
136 Australia
140 South Africa
562 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG;1GM, TABLET;ORAL - 2.5MG;500MG, TABLET;ORAL - 2.5MG;850MG, TABLET;ORAL - EQ 12.5MG BASE;1GM, TABLET;ORAL - EQ 12.5MG BASE;500MG, TABLET;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM, TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG, TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM, TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG, TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION, EXTENDED RELEASE;ORAL - 500MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 500MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 1GM, TABLET, EXTENDED RELEASE;ORAL - 500MG, TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 850MG;EQ 15MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE, TABLET;ORAL - 1GM;EQ 50MG BASE, TABLET;ORAL - 500MG;EQ 50MG BASE, TABLET;ORAL - 500MG;1MG, TABLET;ORAL - 500MG;2MG

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2.5MG;1GM
TABLET;ORAL - 2.5MG;500MG
TABLET;ORAL - 2.5MG;850MG
TABLET;ORAL - EQ 12.5MG BASE;1GM
TABLET;ORAL - EQ 12.5MG BASE;500MG
TABLET;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM
TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG
TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM
TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG
TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION, EXTENDED RELEASE;ORAL - 500MG/5ML
TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - 500MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 1GM
TABLET, EXTENDED RELEASE;ORAL - 500MG
TABLET;ORAL - 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 850MG;EQ 15MG BASE
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 15MG BASE
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 30MG BASE
TABLET;ORAL - 1GM;EQ 50MG BASE
TABLET;ORAL - 500MG;EQ 50MG BASE
TABLET;ORAL - 500MG;1MG
TABLET;ORAL - 500MG;2MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Minakem, 8 Evonik, 7 Rochem International Inc, 23 SPI Pharma, 19 DKSH, 2 Pharm-RX Chemical, 13 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 6 Kirsch Pharma, 1 ACG Worldwide, 12 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 1 Avesta Pharma, 38 BASF, 1 Bioplus Life Sciences, 2 CD Formulation, 2 Clariant, 27 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 5 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 5 Lubrizol Life Science Health, 22 Microlex e.U, 2 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 11 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 35 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

108 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 57 Direct Compression, 54 Thickeners and Stabilizers, 52 Disintegrants & Superdisintegrants, 52 Controlled & Modified Release, 48 Solubilizers, 46 Granulation, 42 Taste Masking, 40 Film Formers & Plasticizers, 39 Topical, 32 Parenteral, 30 Lubricants & Glidants, 25 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 15 Emulsifying Agents, 15 Rheology Modifiers, 11 API Stability Enhancers, 8 Surfactant & Foaming Agents, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

108 Fillers, Diluents & Binders
63 Coating Systems & Additives
57 Direct Compression
54 Thickeners and Stabilizers
52 Disintegrants & Superdisintegrants
52 Controlled & Modified Release
48 Solubilizers
46 Granulation
42 Taste Masking
40 Film Formers & Plasticizers
39 Topical
32 Parenteral
30 Lubricants & Glidants
25 Chewable & Orodispersible Aids
16 Co-Processed Excipients
15 Emulsifying Agents
15 Rheology Modifiers
11 API Stability Enhancers
8 Surfactant & Foaming Agents
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 374 News #PharmaBuzz

1 Data Compilation #PharmaFlow
374 News #PharmaBuzz

GLOBAL SALES INFORMATION

96 US Medicaid Prescriptions, 494 Regulatory FDF Prices, 58 Annual Reports

96 US Medicaid Prescriptions
494 Regulatory FDF Prices
58 Annual Reports

MARKET PLACE

92 APIs, 51 FDF Dossiers

92 APIs
51 FDF Dossiers

PATENTS & EXCLUSIVITIES

619 US Patents, 54 US Exclusivities, 156 Health Canada Patents

619 US Patents
54 US Exclusivities
156 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 17 Others

3 EDQM
1 USP
17 Others

ANALYTICAL

2 BioAnalytical Methods, 1 Analytical Methods

2 BioAnalytical Methods
1 Analytical Methods

$ API Ref.Price (USD/KG) : 4 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

58 All

01 6Equa/EquMet

02 4Galvus

03 5Galvus Group

04 2Glumetza

05 7Invokana/Invokamet

06 16Janumet

07 11Januvia

08 1Sujanu

09 3Trajenta/ Jentadueto

10 3Trajenta/Jentadueto

Granules Metformin

List of Suppliers

Product Main Page

01

Brand Name : Equa/EquMet

Vildagliptin, Metformin Hydrochloride

CPHI Shenzhen

Not Confirmed

Brand Name : Equa/EquMet

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dainippon Sumitomo

Vildagliptin, Metformin Hydrochloride

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 391

2019 Revenue in Millions : 75

Growth (%) : 421

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Invokana/Invokamet

CPHI Shenzhen

Not Confirmed

Brand Name : Invokana/Invokamet

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Johnson & Johnson

Metformin HCl

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 795

2019 Revenue in Millions : 735

Growth (%) : 8

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Trajenta/ Jentadueto

Vildagliptin, Metformin Hydrochloride

CPHI Shenzhen

Not Confirmed

Brand Name : Trajenta/ Jentadueto

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Boehringer Ingelheim

Vildagliptin, Metformin Hydrochloride

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 1,801

2019 Revenue in Millions : 1,857

Growth (%) : -3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Janumet

Vildagliptin, Metformin Hydrochloride

CPHI Shenzhen

Not Confirmed

Brand Name : Janumet

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Vildagliptin, Metformin Hydrochloride

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 1,971

2019 Revenue in Millions : 2,041

Growth (%) : -3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Januvia

Sitagliptin, Metformin

CPHI Shenzhen

Not Confirmed

Brand Name : Januvia

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Sitagliptin, Metformin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 3,306

2019 Revenue in Millions : 3,482

Growth (%) : -5

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Janumet

Sitagliptin, Metformin

CPHI Shenzhen

Not Confirmed

Brand Name : Janumet

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Sitagliptin, Metformin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 1,971

2019 Revenue in Millions : 2,041

Growth (%) : -3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Galvus Group

Vildagliptin, Metformin Hydrochloride

CPHI Shenzhen

Not Confirmed

Brand Name : Galvus Group

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Vildagliptin, Metformin Hydrochloride

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 1,199

2019 Revenue in Millions : 1,297

Growth (%) : -8

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Trajenta/ Jentadueto

Vildagliptin, Metformin Hydrochloride

CPHI Shenzhen

Not Confirmed

Brand Name : Trajenta/ Jentadueto

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Boehringer Ingelheim

Vildagliptin, Metformin Hydrochloride

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 1,709

2020 Revenue in Millions : 1,801

Growth (%) : 3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Invokana/Invokamet

CPHI Shenzhen

Not Confirmed

Brand Name : Invokana/Invokamet

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Johnson & Johnson

Metformin HCl

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 563

2020 Revenue in Millions : 795

Growth (%) : -29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Galvus Group

Vildagliptin, Metformin Hydrochloride

CPHI Shenzhen

Not Confirmed

Brand Name : Galvus Group

CPHI Shenzhen

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Vildagliptin, Metformin Hydrochloride

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 1,092

2020 Revenue in Millions : 1,199

Growth (%) : -9

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!